O7 Does viral suppressive capacity in cART-treated HIV-infected patients correlate with disease parameters, viral reservoir measures or cytotoxic T cell phenotype?
Main Authors: | P. Pannus, P. Adams, E. Willems, L. Heyndrickx, M. Van Frankenhuijsen, E. Florence, M. Kiselinova, S. Rutsaert, K. Vervisch, W. Despiegelaere, C. Devaux, L. Vandekerckhove, G. Vanham |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-09-01
|
Series: | Journal of Virus Eradication |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2055664020308232 |
Similar Items
-
O3 Quantifying and characterising the HIV reservoir in virally suppressed patients
by: Pieter Pannus, et al.
Published: (2016-09-01) -
OP 3.8 – 00066 Characterization of the HIV-1 viral reservoir in subtype B early treated individuals
by: T. Struyve, et al.
Published: (2022-12-01) -
Control of viral replication after cessation of HAART
by: Buvé Anne, et al.
Published: (2011-02-01) -
Immune and viral correlates of "secondary viral control" after treatment interruption in chronically HIV-1 infected patients.
by: Ellen Van Gulck, et al.
Published: (2012-01-01) -
O2 Cross-validation of HIV DNA assays to quantify different HIV-1 subtypes by ddPCR
by: S. Rutsaert, et al.
Published: (2016-09-01)